LAB

Standard Biotools
$0.78
−$0.06 (−6.96%)Jul 27, 2026
3.4FairMoatMint rating

MoatMint rates Standard Biotools (LAB) 3.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.2 out of 10.

Key metrics

The numbers that frame LAB today
Market cap
$302.54M
P/E (TTM)
3.9
EV / FCF
-0.7
Gross margin
49.6%
EV / Sales
0.8
ROIC
11.7%
Div yield
0%
Debt / equity
0.1
52wk Low
$0.71
52wk High
$1.72

LAB stock rating

How LAB scores on quality, value, growth, momentum and financial health
3.4out of 10
Fair overallFair business, fair priceTop 66% of ~5,000 US stocks
QualityFair2.2/10
GrowthGreat9.8/10
MomentumPoor1.4/10
ValueNeutral5.4/10
Financial HealthGood6.6/10

Growth

Revenue and earnings trend for LAB
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about LAB
Is Standard Biotools a good buy?
No. Standard Biotools has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Standard Biotools is selling at a fair price.
What is the market capitalization of LAB?
Standard Biotools's market capitalization is $302.54M.
What is the P/E ratio for LAB stock?
Standard Biotools's current P/E ratio is 3.9.
What is the 52-week high for LAB stock?
The 52-week high for Standard Biotools is $1.72. The current close of $0.78 is 54.9% below that high.
What is the 52-week low for LAB stock?
The 52-week low for Standard Biotools is $0.71. The current close of $0.78 is 9.9% above that low.
Does LAB stock pay dividends?
Standard Biotools does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LAB?
Standard Biotools's Debt / Equity ratio is 0.05.